- Home
- GO vs VCEL Comparison
GO vs VCEL Comparison
Compare GO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GO
- VCEL
- Stock Information
- Founded
- GO 1946
- VCEL 1989
- Country
- GO United States
- VCEL United States
- Employees
- GO N/A
- VCEL N/A
- Industry
- GO Food Chains
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GO Consumer Staples
- VCEL Health Care
- Exchange
- GO Nasdaq
- VCEL Nasdaq
- Market Cap
- GO 1.8B
- VCEL 2.1B
- IPO Year
- GO 2019
- VCEL 1997
- Fundamental
- Price
- GO $18.32
- VCEL $34.05
- Analyst Decision
- GO Hold
- VCEL Strong Buy
- Analyst Count
- GO 13
- VCEL 6
- Target Price
- GO $16.85
- VCEL $61.50
- AVG Volume (30 Days)
- GO 2.6M
- VCEL 565.9K
- Earning Date
- GO 11-04-2025
- VCEL 07-31-2025
- Dividend Yield
- GO N/A
- VCEL N/A
- EPS Growth
- GO N/A
- VCEL 2045.40
- EPS
- GO 0.08
- VCEL 0.13
- Revenue
- GO $4,511,376,000.00
- VCEL $249,119,000.00
- Revenue This Year
- GO $11.27
- VCEL $18.35
- Revenue Next Year
- GO $5.86
- VCEL $22.47
- P/E Ratio
- GO $220.40
- VCEL $256.98
- Revenue Growth
- GO 8.47
- VCEL 16.13
- 52 Week Low
- GO $10.26
- VCEL $33.09
- 52 Week High
- GO $21.67
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- GO 60.73
- VCEL 40.14
- Support Level
- GO $17.78
- VCEL $33.34
- Resistance Level
- GO $18.79
- VCEL $36.81
- Average True Range (ATR)
- GO 0.61
- VCEL 1.36
- MACD
- GO -0.18
- VCEL -0.13
- Stochastic Oscillator
- GO 46.78
- VCEL 20.14
About GO Grocery Outlet Holding Corp.
Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.